1. Alemtuzumab for treatingrelapsing-remitting multiple sclerosisIssued: May 2014NICE technology appraisal guidance 312guidance.nice.org.uk/ta312NICE has accredited the process…
Slide 1 Making Comfortable Treatment Decisions : Tips for Thinking Clearly about Benefits and Risks Slide 2 Outline for Today From zero options to nine and counting… Factors…